Development of an apoptotic lentogenic Newcastle disease virus strain by incorporating the p30 protein of African swine fever virus
Virology · 2025-05 · 606 · 110477
DOI: 10.1016/j.virol.2025.110477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virology, 2025-05. Verfasst von Nilave Ranjan Bora und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India. Hauptthemen laut MEDLINE: Newcastle disease virus, Apoptosis, African Swine Fever Virus, Oncolytic Virotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Department of Biotechnology.
Abstract (Originalsprache)
Virotherapy is one of the emerging approaches for cancer treatment. Newcastle disease virus (NDV) is a well-studied avian paramyxovirus commonly isolated from birds. Typically, the virulent strains of NDV are acknowledged for their oncolytic properties. The anti-tumor effects of NDV rely on its capacity to trigger apoptosis in cancer cells and elicit inflammatory immune responses against the tumor. However, the virulent strains pose significant challenges for clinical application. This study investigated the development of an apoptotic lentogenic strain of NDV by incorporating the p30 protein gene of the African swine fever virus (ASFV). Previous studies have indicated that the p30 protein interacts with various cellular proteins, including PARP9 and DAB2, which suggests its potential for direct or indirect influence on apoptotic pathways. Our initial data confirmed the upregulation of caspase 3/9, PARP, and cytochrome c, suggesting the pro-apoptotic nature of the p30 protein. Further, a recombinant NDV (rNDV) expressing p30 protein (rNDV-p30) was developed, and its effects were evaluated on human breast cancer (MCF-7) cells. While rNDV alone can't show apoptosis, its variant, rNDV-p30 showed promising apoptotic features in MCF-7 cells. Overall, the results demonstrated the development of rNDV-p30 as an apoptotic virus that offered a novel virotherapy strategy for cancer treatment. Additional research is needed to investigate the underlying mechanisms, safety, and efficacy of the apoptotic activity of the rNDV-p30 and to evaluate the effectiveness of this approach in animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India.
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India. Electronic address: sachinku@iitg.ac.in.
Förderung
- Department of Biotechnology
Zitieren
APA
Bora, N. R., Kumar, R., & Kumar, S. (2025). Development of an apoptotic lentogenic Newcastle disease virus strain by incorporating the p30 protein of African swine fever virus. Virology, 606, 110477. https://doi.org/10.1016/j.virol.2025.110477
Vancouver
Bora NR, Kumar R, Kumar S. Development of an apoptotic lentogenic Newcastle disease virus strain by incorporating the p30 protein of African swine fever virus. Virology. 2025;606:110477. doi:10.1016/j.virol.2025.110477
BibTeX
@article{Bora2025,
author = {Bora, Nilave Ranjan and Kumar, Rakesh and Kumar, Sachin},
title = {Development of an apoptotic lentogenic Newcastle disease virus strain by incorporating the p30 protein of African swine fever virus},
journal = {Virology},
year = {2025},
volume = {606},
pages = {110477},
doi = {10.1016/j.virol.2025.110477}
}
EUVIMED